Breast Localization: RFID Tags vs Wire Localization

NCT04750889 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2023-06-18

No results posted yet for this study

Summary

The RFID trial focuses on breast localization in patients with non-palpable breast cancers. It aims to demonstrate the improvement in patient comfort when using the Radio Frequency Identification (RFID) tag and LOCalizer™ device compared to the gold standard device.

Conditions

  • Breast Neoplasm Female

Interventions

DEVICE

RFID tags

Installation of the RFID tag device wire localization)

DEVICE

Wire localization

Installation of the wire localization device

Sponsors & Collaborators

  • Centre Jean Perrin

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-15
Primary Completion
2023-04-24
Completion
2023-04-24

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04750889 on ClinicalTrials.gov